ArticleNano-micro letters2025
Te-Modulated Fe Single Atom with Synergistic Bidirectional Catalysis for High-Rate and Long-Cycling Lithium-Sulfur Battery.
Article in Nano-micro letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Synergistic Integration of Fe-NAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Practical Lithium-Sulfur Batteries: An Integrated Design Roadmap from High-Loading Cathodes to High-Energy Pouch Cells.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
- Facilitated Polysulfide Redox Conversion by Delocalized Electrons in MBene Heterointerface for Highly Stable Lithium-Sulfur Batteries.Nano-micro letters · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Single-atom catalysts (SACs) have garnered significant attention in lithium-sulfur (Li-S) batteries for their potential to mitigate the severe polysulfide shuttle effect and sluggish redox kinetics. However, the development of highly efficient SACs and a comprehensive understanding of their structure-activity relationships remain enormously challenging. Herein, a novel kind of Fe-based SAC featuring an asymmetric FeN
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.